Hypertension among Middle Eastern and North African adults residing in the United States: addressing equity in health research representation using the All of Us Research Program, 2000–2024 - Scorecard - MDSpire
Advertisement
Hypertension among Middle Eastern and North African adults residing in the United States: addressing equity in health research representation using the All of Us Research Program, 2000–2024
Clinical Scorecard: Prevalence and Management of Hypertension in Middle Eastern and North African Adults Living in the United States: Enhancing Health Research Equity through the All of Us Research Program, 2000–2024
At a Glance
Category
Detail
Condition
Key Mechanisms
Cardiometabolic conditions, including diabetes, chronic kidney disease, coronary artery disease, hyperlipidemia, sleep apnea, obesity, and vitamin D deficiency.
Target Population
Care Setting
Key Highlights
18% of MENA adults had hypertension.
76% of hypertensive participants received antihypertensive treatment.
85% of treated participants achieved blood pressure control.
Higher BP control in participants aged ≤ 50 years (97%) compared to those aged >50 years (83%).
Significant predictors of HTN include diabetes, chronic kidney disease, and obesity.
Guideline-Based Recommendations
Diagnosis
HTN defined by outpatient diagnosis of essential HTN.
Management
Antihypertensive treatment for 76% of hypertensive participants.
Monitoring & Follow-up
BP control assessed as BP < 140/90 mm Hg in ≥50% of outpatient visits.
Risks
Cardiometabolic conditions are primary drivers of HTN risk.
Patient & Prescribing Data
MENA adults aged ≥18 years with at least one outpatient blood pressure measurement.
Higher treatment and BP control rates compared to general US population.
